Abliva AB
STO:ABLI

Watchlist Manager
Abliva AB Logo
Abliva AB
STO:ABLI
Watchlist
Price: 0.444 SEK 0.23%
Market Cap: 715.7m SEK

Net Margin
Abliva AB

0%
Current
-111 655.8%
Average
-6.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-90m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

Abliva AB
Glance View

Market Cap
715.7m SEK
Industry
Biotechnology

Abliva AB is a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of primary mitochondrial diseases. The company is headquartered in Lund, Skane. The company went IPO on 2008-10-03. The firm focuses on the development of novel treatments for primary mitochondrial diseases.

ABLI Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-90m
/
Revenue
0
What is the Net Margin of Abliva AB?

Based on Abliva AB's most recent financial statements, the company has Net Margin of 0%.

Back to Top